Meeting Report From "Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID-19 Pandemic"

Affiliations

• ¹ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
• ² Center for Vaccine Research and Pandemic Preparedness (C-VaRPP), Icahn School of Medicine at Mount Sinai, New York, New York, USA.
• ³ Department of Pathology, Molecular and Cell Based Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
• ⁴ Ignaz Semmelweis Institute, Interuniversity Institute for Infection Research, Medical University of Vienna, Vienna, Austria.
• ⁵ The Task Force for Global Health, Decatur, Georgia, USA.
• ⁶ Science Research & Innovation, Medicines and Healthcare products Regulatory Agency, Potters Bar, UK.
• ⁷ Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (DMID/NIAID/NIH), Rockville, Maryland, USA.
• ⁸ WHO Collaborating Centre for Reference and Research on Influenza, Royal Melbourne Hospital, and Department of Infectious Diseases, University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Melbourne, Australia.
• ⁹ Department of Epidemiology, University of California, Los Angeles, Los Angeles, California, USA.
• ¹⁰ Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA.
• ¹¹ Center for Influenza Disease and Emergence Response (CIDER), University of Georgia, Athens, Georgia, USA.
• ¹² Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA.
• ¹³ Department of Infectious Diseases, Imperial College London, London, UK.
• ¹⁴ Department of Host-Microbe Interactions, St Jude Children's Research Hospital, Memphis, Tennessee, USA.
• ¹⁵ Influenza Centre, Department of Clinical Science, University of Bergen, Bergen, Norway.
• ¹⁶ Department of Microbiology, Haukeland University Hospital, Bergen, Norway.